1. Home
  2. CTSO vs INLX Comparison

CTSO vs INLX Comparison

Compare CTSO & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • INLX
  • Stock Information
  • Founded
  • CTSO 1997
  • INLX 1996
  • Country
  • CTSO United States
  • INLX United States
  • Employees
  • CTSO N/A
  • INLX N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • INLX EDP Services
  • Sector
  • CTSO Health Care
  • INLX Technology
  • Exchange
  • CTSO Nasdaq
  • INLX Nasdaq
  • Market Cap
  • CTSO 68.2M
  • INLX 60.5M
  • IPO Year
  • CTSO N/A
  • INLX N/A
  • Fundamental
  • Price
  • CTSO $0.87
  • INLX $13.50
  • Analyst Decision
  • CTSO Strong Buy
  • INLX
  • Analyst Count
  • CTSO 3
  • INLX 0
  • Target Price
  • CTSO $4.67
  • INLX N/A
  • AVG Volume (30 Days)
  • CTSO 138.6K
  • INLX 2.8K
  • Earning Date
  • CTSO 05-14-2025
  • INLX 05-16-2025
  • Dividend Yield
  • CTSO N/A
  • INLX N/A
  • EPS Growth
  • CTSO N/A
  • INLX N/A
  • EPS
  • CTSO N/A
  • INLX N/A
  • Revenue
  • CTSO $35,594,520.00
  • INLX $18,018,373.00
  • Revenue This Year
  • CTSO $18.72
  • INLX $7.58
  • Revenue Next Year
  • CTSO $19.75
  • INLX N/A
  • P/E Ratio
  • CTSO N/A
  • INLX N/A
  • Revenue Growth
  • CTSO 14.51
  • INLX 6.70
  • 52 Week Low
  • CTSO $0.70
  • INLX $5.85
  • 52 Week High
  • CTSO $1.61
  • INLX $16.50
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 34.05
  • INLX 48.19
  • Support Level
  • CTSO $0.87
  • INLX $12.00
  • Resistance Level
  • CTSO $1.16
  • INLX $15.00
  • Average True Range (ATR)
  • CTSO 0.06
  • INLX 0.68
  • MACD
  • CTSO -0.02
  • INLX -0.12
  • Stochastic Oscillator
  • CTSO 0.34
  • INLX 40.31

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

Share on Social Networks: